Form 4: REGENXBIO CEO Sells Shares for Tax Obligations Following RSU Vesting

REGENXBIO Inc.'s Chief Executive Officer, Curran Simpson, disposed of 4,701 shares of common stock valued at $8.23 per share to cover tax obligations related to the vesting of restricted stock units.

Summary

• Curran Simpson, the Chief Executive Officer and a Director of REGENXBIO Inc. (RGNX), reported a transaction involving the company's common stock.
• On July 1, 2025, Mr. Simpson disposed of 4,701 shares of common stock.
• The disposition was a 'F' transaction code, indicating shares withheld to pay taxes upon the vesting of restricted stock units (RSUs).
• These RSUs were originally granted to Mr. Simpson on July 1, 2024.
• The price per share for the disposition was $8.23, which was determined based on the closing price of REGENXBIO's common stock on July 1, 2025.
• Following this reported transaction, Curran Simpson beneficially owns 252,331 shares of REGENXBIO Inc. common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary event related to executive compensation (tax withholding upon RSU vesting) and does not reflect a change in sentiment or strategic direction for the company. It is neutral in its implications for investors.

Positives

• The transaction represents the vesting of restricted stock units, which is a form of compensation and indicates continued employment and performance by the CEO.

Negatives

• The disposition of shares was solely for tax withholding purposes upon the vesting of restricted stock units, and not a discretionary sale, therefore it does not indicate a negative outlook on the company by the insider.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to executive compensation and does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not a sale indicating lack of confidence.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

Keywords

REGENXBIO, RGNX, Curran Simpson, CEO, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Tax Withholding, Common Stock